Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
about
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerTreatment of diabetes and long-term survival after insulin and glucokinase gene therapy.Adeno-associated virus activates an innate immune response in normal human cells but not in osteosarcoma cells.Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosaImmunity to adeno-associated virus vectors in animals and humans: a continued challenge.Tracing fasting glucose fluxes with unstressed catheter approach in streptozotocin induced diabetic ratsRestoring insulin production for type 1 diabetes.Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside.The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistanceLong-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction.High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency.Hyperglycemia and hepatic tumors in ICR mice neonatally injected with streptozotocin.Regenerative medicine and cell-based approaches to restore pancreatic function.Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
P2860
Q24615809-1618C97B-6A61-4B2C-B0BA-5C59160B15CAQ30539199-211DA233-6CFF-41A6-BA4D-9E6D4FD742A9Q35599302-CE837328-C89E-415B-A3E0-695AF02AAAC7Q36469478-7DBB6A47-E96E-401B-8A40-94A82B3C3F8CQ37127246-8BFAAC09-0C55-4EB0-AAAA-C80670950F1AQ37687223-5F4CA422-4D71-4217-AF33-6BF13E911346Q37994917-E7099DCE-FF05-4290-B200-C64FA95710CAQ38195598-73798E7B-1E7F-4A55-B088-E90B9BFA36CDQ38262028-A0B03DAE-EA40-4CD1-8061-5369D56E87D9Q39137705-92763A31-A55D-4B70-BB4A-99BB6BF2B9B7Q40155189-B1DFA8A7-2055-41DC-8F3A-9C011AD9BB9CQ41866974-2C254867-59A4-4D50-BDD9-80564DC2F86EQ45855465-61F3001B-68FE-46CA-998E-0D0B4425AD10Q51133215-878F3682-5C98-48FD-89CA-8C20879F9850Q52543005-53C6CBE0-75F2-472C-84C9-BA2DF65294FCQ54551322-1737B770-1AAD-49AC-A125-761A408CDEA6
P2860
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@en
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@nl
type
label
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@en
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@nl
prefLabel
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@en
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.
@nl
P2093
P50
P356
P1433
P1476
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle
@en
P2093
Anne M Douar
Joel Montané
Pedro Otaegui
P304
P356
10.2337/DB05-1615
P407
P577
2006-06-01T00:00:00Z